Final Results From The Zenith-1 Study: Oral Administration Of Plasma Kallikrein Inhibitor Bcx7353 For The Treatment Of Attacks In Patients With Hereditary AngioedemaH. J. Longhurst,M. Stobiecki,A. Zanichelli,A. Huissoon,D. Moldovan,M. Maurer,M. Magerl,M. Cancian,R. Senter, A. Manson,E. Aygoeren-Puersuen,V Grivcheva-Panovska,D. Hagin,U. Steiner, S. Kiani-Alikhan,N. Agmon-Levin,A. Bygum,W. Aberer,S. N. Faust,D. Launay,M. Gompels,M. Triggiani, C. Bethune,A. Reshef,M. Cornpropst,S. Dobo, S. Van Dyke, S. Murray,P. Collis,W. P. Sheridan,H. Farkas,M. CicardiALLERGY（2019）引用 2|浏览36暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
